Jump to content
Forum | Advancement | Career | Veteran

Sign in to follow this  
Tony

NOTIFICATION OF DRUG TESTING PROGRAM REVISIONS - INITIATION OF FENTANYL AND NORFENTANYL TESTING

Rate this topic

Recommended Posts

Tony
UNCLASSIFIED//
ROUTINE
R 031653Z JUN 19
FM CNO WASHINGTON DC
TO NAVADMIN
INFO CNO WASHINGTON DC
BT
UNCLAS

NAVADMIN 125/19

PASS TO OFFICE CODES:
FM CNO WASHINGTON DC//N1//
INFO CNO WASHINGTON DC//N1//
MSGID/GENADMIN/CNO WASHINGTON DC/N1/JUN//

SUBJ/NOTIFICATION OF DRUG TESTING PROGRAM REVISIONS - INITIATION OF FENTANYL 
AND NORFENTANYL TESTING//

REF/A/DOC/DOD/29MAR19//
REF/B/DOC/OPNAV/4JUN09//
NARR/REF A IS DEPARTMENT OF DEFENSE (DOD) NOTICE OF THE EXPANSION OF DOD 
PANEL OF TESTED DRUGS TO INCLUDE FENTANYL AND NORFENTANYL.  
REF B IS OPNAVINST 5350.4D, NAVY ALCOHOL AND DRUG ABUSE PREVENTION AND 
CONTROL.

RMKS/1.  This NAVADMIN announces the expansion of the Department of Defenses 
ability to conduct random drug testing for the manufactured opiates Fentanyl 
and Norfentanyl.  Members determined as abusing drugs face punitive action 
under the Uniform Code of Military Justice, Article 112a.  Effective 
immediately, Navy Drug Screening Laboratories will add Fentanyl and 
Norfentanyl to the standard drug testing panel for urinalysis samples 
submitted for testing as announced in reference (a).

2.  Navy policy remains clear with regards to substance abuse:  zero 
tolerance.  Sailors determined as using drugs shall be disciplined as 
appropriate and processed for administrative separation and may receive an 
Other than Honorable characterization of service which could affect their 
veteran benefits and employment opportunities.
Additionally, the Navy reports unlawful drug users to the Federal Bureau of 
Investigation for inclusion in the National Instant Criminal Background Check 
System, which impacts the ability to purchase firearms or ammunition.  It is 
the responsibility of every Sailor to ensure that he or she is diligent in 
avoiding intentional or accidental exposure to federally-prohibited 
substances.

3.  Point of contact is Mrs. LaNorfeia Parker, Director, Navy Drug Detection 
and Deterrence, OPNAV N17, at (901) 874-4249/DSN 882 or via e-mail at 
lanorfeia.parker(at)navy.mil.

4.  Released by Vice Admiral John B. Nowell, Jr, N1.//

BT
#0001
NNNN
UNCLASSIFIED//

Share this post


Link to post
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Sign in to follow this  

  • Who's Online   1 Member, 0 Anonymous, 14 Guests (See full list)

    • kneppercr


×
×
  • Create New...